UE LifeSciences Inc.

iBreastExam is an FDA cleared hand-held device enabling primary health workers to identify breast lumps early, in just a few minutes, without any pain or radiation 2 million+ breast exams enabled in 12 countries clinically validated in 25,000+ women Innovative Health Technology Recognition 2022 Global  Women's HealthTech Award Grants4Impact  Award Recipient Global Health Innovation Grant Winner (Twice) Thought Leader Recognition Cure Grant Award Recipient  iBreastExam is enabling access to early detection like never before Breast Cancer Screening: Can iBreastExam Bridge the Gap? Lancet Global Health Independent Review by Nigerian Cancer Researchers Read Paper Leading Cancer Center Brings iBreastExam to Women in NY Campaign by Montefiore Einstein Cancer Center and Rotary Club Hudson Valley Video iBreastExam Presented at 2022 World Cancer Congress "We're honored to have UE LifeSciences join UICC and the global cancer community" - Cary Adams, CEO, UICC Video Accuracy of iBreastExam as a Screening Modality Independent Study by Governmental Institution in 18,366 Women Read Paper US Market Launch with Siemens Healthineers UE LifeSciences’ iBreastExam clearly addresses a well-defined niche in primary care Press Release Large Scale Screening Campaign in Rural India Door-to-Door campaign is bringing breast cancer early detection to 250,000 women Video Reputable Global Validations Lancet | ASCO | SABCS | WJSO NYTimes Op-Ed Article TED Talk with Shahrukh Khan BBC News Feature Video Forbes Article Real feedback from real women "It's good to have first-hand information before going for a full check-up" - Maria, Mexico "Excellent! No Pain. Instant Results." - Pooja, India "It really helps to know about yourself, which we avoid in our day-to-day life" - Jaya, Myanmar "A step to make women feel that their health is important" - Joomi, Botswana iBreastExam is brought to you by UE LifeSciences